ESMO Breast 2020: will you be among the contributors to the latest data in breast cancer? Submit your abstract by 4 February 2020
The latest standards in the field. Register by 20 November 2019 to discover them
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates.
The ESMO-MCBS scale is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Dr. Florian Lordick expresses his enthusiasm for his appointment as ESMO Director of Education and shares his vision for the 2020-2021 Directorship
18 Nov 2019
Meeting resources from EMUC 2019 are open to all!
18 Nov 2019
New indication concerns adjuvant treatment of adult patients with HER2-positive early breast cancer who have residual invasive disease
15 Nov 2019
The results of the GOG-0213 study
14 Nov 2019
The results of KEYNOTE-158 study
13 Nov 2019
Researchers uncover how immune checkpoint inhibitor response relies on the evolved efficiency of HLA-mediated immunity
12 Nov 2019
Evidence for efficacy is based on the results from the BELIEVE trial
Singapore
20 Nov
- 21 Nov
2019
Singapore, Singapore
22 Nov
- 24 Nov
2019
Singapore
25 Nov
- 26 Nov
2019
Zurich, Switzerland
28 Nov
- 29 Nov
2019
Lugano, Switzerland
29 Nov
- 30 Nov
2019
Paris, France
06 Dec
- 07 Dec
2019
